NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.

NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: ناصر صمدی , کبری ولائی , جعفر سلیمانی راد

کلمات کلیدی: ABC transporters  Chemoresistance phenotype  Breast cancer  NFjBP65  Resistance to doxorubicin

نشریه: 5278 , 4 , 24 , 2017

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله کبری ولائی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پزشکی
کد مقاله 59582
عنوان فارسی مقاله NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
عنوان لاتین مقاله NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت http://link.springer.com/article/10.1007%2Fs12282-016-0738-8

خلاصه مقاله
hide/show

BACKGROUND: Shedding light on chemoresistance biology of breast cancer could contribute to enhance the clinical outcome. Intrinsic or acquired resistance to chemotherapy is a major problem in breast cancer treatment. METHODS AND MATERIALS: The NFκB pathway by siRNAP65 and JSH-23 as a translocational inhibitor of NFκBP65 in the doxorubicin-resistant MCF-7 (MCF-7/Dox) and MCF-7 cells was blocked. Then, the ABC transporter expression and function were assessed by real-time qRT-PCR and flow cytometry, respectively. Induction of apoptosis was evaluated after inhibition of the NFΚB pathway as well. RESULTS: Our study underlined the upregulation of NFκBP65 and anti-apoptotic Bcl-2 and downregulation of pro-apoptotic Bax in the MCF-7/Dox cells compared with control MCF-7 cells. Here, we showed that interplay between nuclear factor kappa B P65 (NFkBP65) as a transcriptional regulator and ABC transporters in the MCF-7/Dox cancer cells. We found that inhibition of the elevated expression of NFκBP65 in the resistant breast cancer, whether translocational inhibition or silencing by siRNA, decreased the expression and function of MDR1 and MRP1 efflux pumps. Furthermore, the blockade of NFκBP65 promoted apoptosis via modulating Bcl-2 and BAX expression. After inhibition of the NFκBP65 signaling pathway, elevated baseline expression of survival Bcl-2 gene in the resistant breast cells significantly decreased. CONCLUSION: Suppression of the NFκB pathway has a profound dual impact on promoting the intrinsic apoptotic pathway and reducing ABC transporter function and expression, which are some of the chemoresistance features. It was speculated that the NFκB pathway directly acts on doxorubicin-induced MDR1 and MRP1 expression in MCF-7/Dox cells.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
ناصر صمدیدوم
کبری ولائیاول
جعفر سلیمانی رادپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
velaei2016.pdf1395/09/273206595دانلود
velaii.pdf1401/11/19139231دانلود